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Introduction 
Autosomal dominant, hereditary angio-oedema is 
characterized by episodic swelling of the extremities, 
face, neck, airway and gastrointestinal tract (1). 
Attacks are precipitated by minor local trauma in 
about 50% of cases, although anxiety and emotional 
stress are also associated with an increased frequency 
of attacks (2). Without treatment, the condition 
carries a mortality rate of 30% attributed to airway 
obstruction due to laryngeal oedema (1). Surgery and 
instrumentation of the oropharynx in particular, 
result in a high incidence of laryngeal oedema (2). 
Agents such as anti-fibrinolytics [epsilon amino 
caproic acid (EACA) and tranexamic acid], fresh 
frozen plasma (FFP) and Cl esterase inhibitor 
(Cl Inh) have been used to decrease the incidence of 
laryngeal oedema during instrumentation (3-6). 
Cl Inh has also been shown to be effective in the 
treatment of acute attacks (7). We report a successful 
case of bronchoscopy in a 64-year-old woman with 
hereditary angio-oedema. 
Case Report 
A 64-year-old mother of four presented with a 3 
month history of hoarseness and worsening breath- 
lessness. On further questioning, she admitted to a 
dry cough, posterior chest pain and weight loss of 1.5 
stone. She had a 40 pack/year smoking history. 
Hereditary angio-oedema had been diagnosed 30 yr 
previously, and 2 yr prior to presentation, she had 
suffered a cardio-respiratory arrest due to tonsillitis- 
associated laryngeal oedema. She had been admitted 
twice in the previous year with attacks of peripheral 
oedema and facial swelling, despite danazol therapy 
which had been subsequently stopped due to unac- 
ceptable weight gain and hirsutism. The typical 
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Plate I Chest X-ray showing a x 9 cm left upper lobe 
mass adjacent to the superior mediastinum. 
findings of deficiency of Cl Inh and subnormal 
levels of C4 had been confnmed [Cl Inh 0.05 g I- ’ 
(normal range 0.15-0.35), C3 1.0 g 1 - ’ (0.7-1.7), C4 
0.06 g l- ’ (0.2--0.65)]. She was on no regular medi- 
cation, a course of oral corticosteroids having been 
stopped 3 weeks previously. All four children were 
also affected by angio-oedema. 
Examination revealed decreased air entry in the 
left upper chest, and a chest X-ray (Plate 1) showed 
the presence of a x 9 cm left upper lobe mass ad- 
jacent to the superior mediastinum. Bronchoscopy 
was planned, and the opportunity taken to monitor 
complement activity throughout the procedure. 
No prophylactic treatment was given, but Cl Inh 
concentrate (Immuno AG, Vienna, Austria) and 
resuscitative facilities were made available. 
Bronchoscopy proceeded uneventfully using topi- 
cal anaesthesia of 4 and 2% lignocaine (Biorex, 
England) alone. The left vocal cord was immobile. 
The trachea, main carina, right bronchial tree and 
left lower lobe appeared normal. The left upper lobe 
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Table I Complement activity prior, during and after bron- 
choscopy 
Complement 
Time after procedure (h) 
Reference range 
component Prior 0.5 1.0 24 k-9 
Cl Inh 0.06 0.06 0.05 0.06 0.15-0.35 
c3 0.90 0.90 0.90 0.86 0.7-1.7 
c4 0.09 0.08 0.09 0.08 0.02-0.65 
bronchus was extrinsically compressed with some 
overlying mucosal irregularity. Lavage of the left 
upper lobe together with brushings and biopsies of 
the abnormal mucosal area were performed. Comple- 
ment activity was measured prior to bronchoscopy, 
during and after the procedure. No evidence of 
complement activation was seen. There was no sig- 
nificant decrease in total C3 during the procedure 
(Table 1). The patient remained well following bron- 
choscopy. Histology and cytology subsequently con- 
firmed an undifferentiated large cell carcinoma. She 
was discharged 1 week later, following staging inves- 
tigations and radiotherapy referral. She has since 
undergone 10 fractions of radiotherapy and suffered 
two episodes of oedema, one peripheral and one of 
the tongue. Both resolved with injections of Cl Inh 
concentration (1500 units). 
Discussion 
Long term prophylactic therapy is not required in 
all patients with hereditary angio-oedema, and is 
contra-indicated in childhood and pregnancy (7). 
However, in patients with life-threatening laryngeal 
oedema and recurrent debilitating attacks, anti- 
fibrinolytics, androgens and Cl Inh have been shown 
to reduce spontaneous episodes and provide effective 
prophylaxis peri-operatively (7-10). The use of FFP 
is currently discouraged, as although it contains 
Cl Inh it also contains C3 and C4, thus providing 
substrates for prolongation of an attack (7). Anti- 
fibrinolytic usage is limited by an increased risk of 
thrombosis and phlebitis, which may be especially 
dangerous when combined with the hypercoagulable 
state associated with malignancy. A period of prepar- 
ation is also required when using most prophylactic 
agents, thus delaying urgent procedures. Corticoster- 
oids, anti-histamines and adrenaline are frequently 
used in the management of acute attacks in heredi- 
tary angio-oedema, as had been the case here, 
although there are no controlled studies that 
demonstrate the efficacy of these agents (1). 
There are no previous reports of carcinoma of the 
lung in hereditary angio-oedema, although angio- 
oedema has been associated with lymphoproliferative 
disorders (11). We felt that this carcinoma was 
smoking related. 
Responses to trauma in hereditary angio-oedema 
have been shown to be variable in each patient (1). 
Bronchoscopy was uneventful in this case, but may 
not be so in all patients. Therefore, CT Inh and 
facilities for intubation and resuscitation should be 
available when instrumentation and investigation of 
the airway in patients with hereditary angio-oedema 
are attempted. 
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